The burden of anaemia in type 2 diabetes and the role of nephropathy: a cross-sectional audit
- 21 April 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 19 (7), 1792-1797
- https://doi.org/10.1093/ndt/gfh248
Abstract
Anaemia is a common finding in patients with diabetes and constitutes an additional burden in patients with advancing age and comorbid vascular disease. This study examines the prevalence and predictors of anaemia in long-term outpatients with type 2 diabetes from three large clinical centres. A full blood count was obtained in addition to routine testing in a cross-sectional survey of all patients with type 2 diabetes in long-term follow-up at the Austin Medical Centre, Melbourne (n = 670) and the Royal Prince Alfred Hospital (n = 915) and the Royal North Shore Hospital (n = 540), Sydney, Australia. The prevalence and correlates of anaemia (haemoglobin < 130 g/l in men and < 120 g/l in women) were identified using multivariate logistic regression. Roughly, one in five patients in each centre had anaemia. Patients at greatest risk could be readily identified by the presence of renal disease, manifested as impaired renal function and/or albuminuria in > 75% of patients with anaemia. Patients with diabetes and mild renal impairment [creatinine clearance (CCr) 60-90 ml/min/1.73 m(2)] were twice as likely to have anaemia as those with normal renal function (CCr > 90 ml/min/1.73 m(2)). Diabetics with moderate renal impairment (CCr < 60 ml/min/1.73 m(2)) were also twice as likely to have anaemia as those with mild renal impairment. Patients with anaemia were also more likely to have macrovascular disease, reflecting the high prevalence of nephropathy in these patients. Anaemia is a prevalent finding in patients with type 2 diabetes and represents a significant unrecognized burden. Patients at greatest risk can be identified by the presence of renal disease, either in the form of renal impairment and/or albuminuria.Keywords
This publication has 13 references indexed in Scilit:
- Genetic Variation of the Renin-Angiotensin System and Chronic Kidney Disease Progression in Black Individuals in the Atherosclerosis Risk in Communities StudyJournal of the American Society of Nephrology, 2006
- Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: The ARIC StudyKidney International, 2003
- The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous ironNephrology Dialysis Transplantation, 2003
- Anaemia in patients with diabetes: unrecognised, undetected and untreated?Current Medical Research and Opinion, 2003
- Association of Kidney Function With AnemiaArchives of Internal Medicine, 2002
- Effects of angiotensin-converting enzyme inhibitors on the treatment of anemia with erythropoietinKidney International, 2001
- Why should women have lower reference limits for haemoglobin and ferritin concentrations than men?BMJ, 2001
- Anemia With Erythropoietin Deficiency Occurs Early in Diabetic NephropathyDiabetes Care, 2001
- Predictors of hospitalization and death among pre‐dialysis patients: a retrospective cohort studyNephrology Dialysis Transplantation, 2000
- Insulinopenia in impaired glucose tolerance preservation of insulin response to i.v. arginine and tolbutamideActa Diabetologica, 1980